Navigation Links
Cadence Pharmaceuticals Announces FDA Extends New Drug Application Review for Intravenous Acetaminophen by Three Months
Date:11/13/2009

elay the completion of the review process for the IV acetaminophen NDA, or result in limitations in the indications for use or the inclusion of unfavorable information in the labeling for this product candidate; intense competition from existing and new products, which could diminish the commercial potential for IV acetaminophen; the possibility that the patent rights covering IV acetaminophen may not be sufficient to preclude other intravenous formulations of acetaminophen from being developed by competitors; the company's dependence on IV acetaminophen, which is Cadence's only product candidate; the potential for Cadence to require substantial additional funding in order to obtain regulatory approval for and commercialize IV acetaminophen, and the risk that the company may not be able to raise sufficient capital when needed, or at all; and other risks detailed in Cadence's prior press releases as well as in Cadence's periodic public filings with the Securities and Exchange Commission. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement and Cadence undertakes no obligation to revise or update this press release to reflect events or circumstances after the date hereof. This caution is made under the safe harbor provisions of Section 21E of the Private Securities Litigation Reform Act of 1995.

Cadence(TM) is a trademark of Cadence Pharmaceuticals, Inc. Perfalgan® is a registered trademark of Bristol-Myers Squibb Company.

    Contact:   William R. LaRue
               SVP & Chief Financial Officer
               Cadence Pharmaceuticals, Inc.
               858-436-1400

SOURCE Cadence Pharmaceuticals, Inc.


'/>"/>
SOURCE Cadence Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Cadence Pharmaceuticals Completes Enrollment of Pivotal Phase III Trial for Intravenous Acetaminophen Ahead of Schedule
2. Cadence Pharmaceuticals Reports First Quarter 2008 Financial Results and Provides Clinical Program Update
3. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Second Quarter 2008 Financial Results and Provide a Clinical Program Update on August 7, 2008
4. Cadence Pharmaceuticals Updates Omigard(TM) Clinical Timeline
5. Cadence Pharmaceuticals Reports Third Quarter 2008 Financial Results and Provides Clinical Development Programs Update
6. Cadence Pharmaceuticals Submits Acetavance New Drug Application for the Treatment of Acute Pain and Fever
7. Cadence Pharmaceuticals to Webcast October 7th Analyst Day
8. Cadence Pharmaceuticals CEO Ted Schroeder to Present at the BIOCOM Investor Conference in San Diego on October 27, 2009
9. Cadence Pharmaceuticals CEO Ted Schroeder To Present at the Oppenheimer 20th Annual Healthcare Conference in New York City on November 4, 2009
10. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
11. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... , Aug. 28, 2015 ... the addition of the "Investigation Report on China,s ... Tobramycin is a traditional antibiotic whose eye drop ... the treatment of potential infection or inflammation caused by ... China are able to produce tobramycin, among ...
(Date:8/28/2015)... 2015 Research and ... the "Investigation Report on China,s Insulin Aspart ... Developed by Novo Nordisk, insulin aspart (under ... drug for the treatment of diabetes. Compared with ... insulin analog, starts working fast and reports higher ...
(Date:8/28/2015)...  IP Shakti, LLC, today announced that it has changed ... Logo - http://photos.prnewswire.com/prnh/20150827/261551LOGO ... identity signifies our transformation into a company focused on patent ... patent claim validity." ... Shield™ platform, the Company commenced a corporate re-branding initiative in ...
Breaking Medicine Technology:Investigation Report on China's Tobramycin Market, 2015-2019 2China Insulin Aspart Market Report 2010-2019 - Developed by Novo Nordisk 2IP Shakti, LLC Changes Company Name to Prediqtus, LLC 2
... Sept. 1, 2011 diaDexus, Inc. (OTC Bulletin Board: ... commercialization of patent-protected in vitro diagnostic products ... it plans to present at Baird,s 2011 Health Care ... Eastern Time (6:30 am Pacific Time) at the New ...
... Sept. 1, 2011 Cardium Therapeutics (NYSE Amex: ... Chief Executive Officer, will present at the Rodman & Renshaw ... 2:25 p.m. Eastern Time.  The conference is being held September ... webcast of the Company,s presentation will be available live and ...
Cached Medicine Technology:Cardium to Present at the Rodman & Renshaw Annual Healthcare Investment Conference 2
(Date:8/29/2015)... ... August 29, 2015 , ... Brands like Toppik ... zero standard shipping costs. , “Before, a threshold of $49.00 was required to qualify ... and items qualify for free standard shipping for customers regardless of the item’s selling ...
(Date:8/29/2015)... ... , ... ProDrop Particles includes over 40 particle backdrops designed for use in ... that users can shrink and stretch in the Final Cut Pro X timeline. Choose ... brightness, scale, speed, range, and flare attributes with intuitive controls found in the top-right ...
(Date:8/29/2015)... New York, NY (PRWEB) , ... August 29, ... ... consistently successful results and include treating the localized area with stretching, soft tissue ... and a neutral pelvic position have shown through research to improve treatment ...
(Date:8/29/2015)... ... 2015 , ... Vascular Health Sciences announced today that an ... HP, and that all claims and counterclaims have been irrevocably dismissed. , In ... the United States District Court for the Southern District of Texas for breach ...
(Date:8/28/2015)... Sierra Madre, CA (PRWEB) , ... August 28, ... ... alternative solutions to wound center management, Decatur County Memorial Hospital recently transitioned management ... model of Wound Center Management for their outpatient wound center. , ...
Breaking Medicine News(10 mins):Health News:TheBeautyPlace.com Discounts Shipping on Select Brands 2Health News:FCPX Effects Developer, Pixel Film Studios, Releases ProDrop Particles. 2Health News:NEW APPROACH for Treatment of Recurrent Hamstring Strains and Hamstring Tendinosis is Available for the First Time in NYC 2Health News:NEW APPROACH for Treatment of Recurrent Hamstring Strains and Hamstring Tendinosis is Available for the First Time in NYC 3Health News:Decatur County Memorial Hospital Transitions Wound Center Management To Wound Care Advantage and the Luvo Operating System 2Health News:Decatur County Memorial Hospital Transitions Wound Center Management To Wound Care Advantage and the Luvo Operating System 3Health News:Decatur County Memorial Hospital Transitions Wound Center Management To Wound Care Advantage and the Luvo Operating System 4
... , THURSDAY, June 4 (HealthDay News) -- Ever wonder ... scab after a cut? Researchers have now pinpointed the ... body has an incredible ability to heal from life,s ... principal investigator at the Rowland Institute at Harvard University, ...
... , Remuda Ranch ( www.remudaranch.com ) Reports Many Patients with ... , PHOENIX, June 4 /PRNewswire/ -- ... with eating disorders repeatedly check their body and often in ... http://www.newscom.com/cgi-bin/prnh/20090604/CG27861LOGO ) , , "Sometimes body and weight checking ...
... New York,s Rainbow Room on May 27th ... Damon Runyon Cancer Research Foundation . The Foundation ... funded through competitive and prestigious award programs, targeting all types of ... by Joe Kernen, co-anchor of CNBC ,s flagship ...
... eighth graders present seat belt safety messages for a chance to ... Nickelodeon or area billboards. , , CLEVELAND, June ... the Plaza Lobby stage at the Rock and Roll Hall ... June 6 , to perform songs, screen videos, and present posters ...
... June 04, 2009 - Patients with heart attacks and ... times more likely to experience serious complications after hospital ... department (ED), according to a new study published in ... say that this dramatic difference in rates of serious ...
... in image and information management solutions highlights Enterprise Content ... , , BOSTON, June 4 AMICAS, ... image and information management solutions, today announced that it ... a vendor-neutral archive solution designed to lower the total ...
Cached Medicine News:Health News:Researchers Detect Blood-Clotting Mechanism 2Health News:Body and Weight Checking May Signify an Eating Disorder 2Health News:Body and Weight Checking May Signify an Eating Disorder 3Health News:NYC Benefit Raises $1.4m for the Damon Runyon Cancer Research Foundation, Honors Merck 2Health News:NYC Benefit Raises $1.4m for the Damon Runyon Cancer Research Foundation, Honors Merck 3Health News:Finalists Perform at Rock Hall in Rainbow Babies & Children's Hospital's 'Pause to Click' Contest Encouraging Safety Belt Use for Tweens 2Health News:Crowded emergency departments pose greater risks for patients with heart attacks 2Health News:Crowded emergency departments pose greater risks for patients with heart attacks 3Health News:AMICAS Showcases Vendor-Neutral Archive Solutions at SIIM 2009 2Health News:AMICAS Showcases Vendor-Neutral Archive Solutions at SIIM 2009 3Health News:AMICAS Showcases Vendor-Neutral Archive Solutions at SIIM 2009 4
... 3D Signature is a state of ... that integrates blood, sterile body fluid ... powerful microbiology workstation with comprehensive capabilities. ... identification and where expanded flexibility in ...
The Vitek 2 is a fully automated bacteriology system that performs bacterial identification and susceptibility testing analysis using a standard inoculum. It detects resistance and helps combat bacte...
IDS Rapid ANA II System, a microbial identification system....
IDS Rapid SS/u, a microbial identification system....
Medicine Products: